Galera Therapeutics shares are trading lower by 34.8% during Monday's session. The company said its shares will be delisted due to non-compliance with Nasdaq's continued listing standards.

Short interest in Galera Therapeutics Inc (OTC:GRTX) increased during the last reporting period, rising from 5.28K to 5.46K. This put 0.01% of the company's publicly available shares short.

Galera Therapeutics Background Information (This ... Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.

MALVERN, PA — Galera Therapeutics, Inc ... acquires a beneficial ownership of 10% or more of Galera’s common stock without the Board’s approval. In such an event, every rights holder ...

In other recent news, Galera Therapeutics, Inc. has been facing significant changes in its operations. The pharmaceutical company has been notified of Nasdaq's decision to delist its common stock ...

Company reports second quarter 2024 financial resultsMALVERN, Pa., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Upgrade your Yahoo Finance plan to get complete details for Galera Therapeutics, Inc. Get advanced tools and insights to navigate the markets.

In other recent news, Galera Therapeutics, Inc. has been facing significant changes in its operations. The pharmaceutical company has been notified of Nasdaq's decision to delist its common stock due ...